What was the overall market valuation of the Italy compounding chemotherapy market in 2024?

The overall market valuation was $13.25 Million in 2024. Read More

What is the projected market valuation for the Italy compounding chemotherapy market by 2035?

The projected valuation for 2035 is $25.18 Million. Read More

What is the expected CAGR for the Italy compounding chemotherapy market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is 6.01%. Read More

Which companies are considered key players in the Italy compounding chemotherapy market?

Key players include Fresenius Kabi, Baxter International, Civica Rx, PharMEDium Services, Accredo Health Group, Athenex, Sagent Pharmaceuticals, and B. Braun Melsungen AG. Read More

What were the segment valuations for chemotherapeutic and non-chemotherapeutic doses in 2024?

In 2024, the valuation for chemotherapeutic doses was $8.25 Million, while non-chemotherapeutic doses were valued at $5.0 Million. Read More

How do the valuations for gravimetric and volumetric automated compounding devices compare in 2024?

In 2024, gravimetric automated compounding devices were valued at $5.3 Million, whereas volumetric automated compounding devices were valued at $7.95 Million. Read More

What was the valuation for sterile and non-sterile compounding in 2024?

The valuation for sterile compounding was $8.0 Million, while non-sterile compounding was valued at $5.25 Million in 2024. Read More

What are the projected valuations for technology with and without robotic arms by 2035?

By 2035, technology with robotic arms is projected to reach $10.0 Million, while technology without robotic arms is expected to reach $15.18 Million. Read More

What does the market data suggest about the growth of the Italy compounding chemotherapy market?

The market data suggests a steady growth trajectory, with a projected increase from $13.25 Million in 2024 to $25.18 Million by 2035. Read More

How does the market performance of the Italy compounding chemotherapy market compare across different segments?

The market performance varies, with chemotherapeutic doses showing a valuation of $8.25 Million and volumetric automated compounding devices at $7.95 Million in 2024. Read More

Italy Compounding Chemotherapy Market

ID: MRFR/Pharma/51476-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

Italy Compounding Chemotherapy Market Research Report By Dose (Chemotherapeutic, Non-Chemotherapeutics), By Delivery Method (Gravimetric Automated Compounding Device, Volumetric Automated Compounding Device), By Sterility (Sterile, Non-Sterile) and By Technology (With Robotic Arms, Without Robotic Arms) - Growth & Industry Forecast 2025 To 2035

Italy Compounding Chemotherapy Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Security, Access Control and Robotics, BY Dose (USD Million)
  1. 4.1.1 Chemotherapeutic
  2. 4.1.2 Non-Chemotherapeutics
2. 4.2 Security, Access Control and Robotics, BY Delivery Method (USD Million)
  1. 4.2.1 Gravimetric Automated Compounding Device
  2. 4.2.2 Volumetric Automated Compounding Device
3. 4.3 Security, Access Control and Robotics, BY Sterility (USD Million)
  1. 4.3.1 Sterile
  2. 4.3.2 Non-Sterile
4. 4.4 Security, Access Control and Robotics, BY Technology (USD Million)
  1. 4.4.1 With Robotic Arms
  2. 4.4.2 Without Robotic Arms
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Security, Access Control and Robotics
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Security, Access Control and Robotics
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Fresenius Kabi (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Baxter International (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Civica Rx (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 PharMEDium Services (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Accredo Health Group (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Athenex (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Sagent Pharmaceuticals (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 B. Braun Melsungen AG (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 ITALY MARKET ANALYSIS BY DOSE
3. 6.3 ITALY MARKET ANALYSIS BY DELIVERY METHOD
4. 6.4 ITALY MARKET ANALYSIS BY STERILITY
5. 6.5 ITALY MARKET ANALYSIS BY TECHNOLOGY
6. 6.6 KEY BUYING CRITERIA OF SECURITY, ACCESS CONTROL AND ROBOTICS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF SECURITY, ACCESS CONTROL AND ROBOTICS
9. 6.9 DRIVERS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
11. 6.11 SUPPLY / VALUE CHAIN: SECURITY, ACCESS CONTROL AND ROBOTICS
12. 6.12 SECURITY, ACCESS CONTROL AND ROBOTICS, BY DOSE, 2024 (% SHARE)
13. 6.13 SECURITY, ACCESS CONTROL AND ROBOTICS, BY DOSE, 2024 TO 2035 (USD Million)
14. 6.14 SECURITY, ACCESS CONTROL AND ROBOTICS, BY DELIVERY METHOD, 2024 (% SHARE)
15. 6.15 SECURITY, ACCESS CONTROL AND ROBOTICS, BY DELIVERY METHOD, 2024 TO 2035 (USD Million)
16. 6.16 SECURITY, ACCESS CONTROL AND ROBOTICS, BY STERILITY, 2024 (% SHARE)
17. 6.17 SECURITY, ACCESS CONTROL AND ROBOTICS, BY STERILITY, 2024 TO 2035 (USD Million)
18. 6.18 SECURITY, ACCESS CONTROL AND ROBOTICS, BY TECHNOLOGY, 2024 (% SHARE)
19. 6.19 SECURITY, ACCESS CONTROL AND ROBOTICS, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY DOSE, 2025-2035 (USD Million)
  2. 7.2.2 BY DELIVERY METHOD, 2025-2035 (USD Million)
  3. 7.2.3 BY STERILITY, 2025-2035 (USD Million)
  4. 7.2.4 BY TECHNOLOGY, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Italy Security, Access Control and Robotics Market Segmentation

Security, Access Control and Robotics By Dose (USD Million, 2025-2035)

Chemotherapeutic
Non-Chemotherapeutics

Security, Access Control and Robotics By Delivery Method (USD Million, 2025-2035)

Gravimetric Automated Compounding Device
Volumetric Automated Compounding Device

Security, Access Control and Robotics By Sterility (USD Million, 2025-2035)

Sterile
Non-Sterile

Security, Access Control and Robotics By Technology (USD Million, 2025-2035)

With Robotic Arms
Without Robotic Arms

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”